Delivery Order SPE2DB22D2206-SPE2DB24FGL29
Award Date 4/2/24
Potential Completion Date 4/3/24
Potential Value $42K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,118,918 units of the pharmaceutical product Cyclophosphamide 1 GM/5 ML VL 5ML. The order, valued at $1,449.08, has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical, valued...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cyclophosphamide 1 GM/5 ML VL 5 ML, a pharmaceutical product, with a potential value of $2,080.34 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not part of a set-aside program. In addition to this specific...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563447861 CYCLOPHOSPHAMIDE 2 GM VIALS. The potential value of this contract is $7,551.05 and the performance period runs through January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclophosphamide 2 gm/10 ml vials. The contract has a ceiling value of $3,053.00 and a completion date of June 23, 2025. It is a firm-fixed-price contract and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,424.85 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 1 GM vials, with performance at the contractor's Conshohocken, Pennsylvania facility. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 27, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,809.90 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 2 GM vials, with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract action under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 2 GM vials, with a contract value of $5,508.82 and an ultimate completion date of November 26, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the Defense Logistics Agency's medical supply...
- The Defense Logistics Agency issued a $1,120.68 delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Cyclophosphamide 500 mg vials with an ultimate completion date of February 9, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a $23,476.94 firm fixed-price delivery order from the Defense Logistics Agency on January 7, 2026, for the supply of Cyclophosphamide 2 GM vials, with an ultimate completion date of January 8, 2026. The contract is not set-aside and represents a competitively awarded delivery order. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,126.11 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of pharmaceutical products and medical supplies. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC...